Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
Nathalie Chavarot, Antoine Morel, Marianne Leruez‐Ville, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 4043-4051
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
BMJ (2022), pp. e068632-e068632
Open Access | Times Cited: 390
Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant
Kasama Manothummetha, Nipat Chuleerarux, Anawin Sanguankeo, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e226822-e226822
Open Access | Times Cited: 87
Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients
Eva Schrezenmeier, Héctor Rincón-Arévalo, Annika Jens, et al.
JCI Insight (2022) Vol. 7, Iss. 9
Open Access | Times Cited: 80
Vaccination in patients with kidney failure: lessons from COVID-19
Nina Babel, Christian Hugo, Timm H. Westhoff
Nature Reviews Nephrology (2022) Vol. 18, Iss. 11, pp. 708-723
Open Access | Times Cited: 79
The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic
Ailish Nimmo, Dale Gardiner, Ines Ushiro‐Lumb, et al.
Transplantation (2022) Vol. 106, Iss. 7, pp. 1312-1329
Open Access | Times Cited: 76
Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
Bilgin Osmanodja, Simon Ronicke, Klemens Budde, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2565-2565
Open Access | Times Cited: 76
Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients
Louise Benning, Christian Morath, Marie Bartenschlager, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 7, pp. 1873-1883
Open Access | Times Cited: 46
Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis
Xinpei Chen, De Luo, Bingjie Mei, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 4, pp. 441-456
Open Access | Times Cited: 44
A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients
Atsushi Sakuraba, Alexander Luna, Dejan Micić
Viruses (2022) Vol. 14, Iss. 8, pp. 1822-1822
Open Access | Times Cited: 39
Efficacy and Safety of Third Dose of the COVID-19 Vaccine among Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis
Orly Efros, Roi Anteby, Mirit Halfon, et al.
Vaccines (2022) Vol. 10, Iss. 1, pp. 95-95
Open Access | Times Cited: 37
Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies
Lanying Du, Yang Yang, Xiujuan Zhang, et al.
Nanoscale (2022) Vol. 14, Iss. 4, pp. 1054-1074
Open Access | Times Cited: 31
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis
Hari Shankar Meshram, Vivek Kute, Hemant Rane, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 6
Open Access | Times Cited: 30
Early Administration of Anti–SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients
Juliette Gueguen, Charlotte Colosio, Arnaud Del Bello, et al.
Kidney International Reports (2022) Vol. 7, Iss. 6, pp. 1241-1247
Open Access | Times Cited: 28
SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients
Quentin Perrier, Julien Lupo, Théophile Gerster, et al.
Vaccine (2022) Vol. 40, Iss. 44, pp. 6404-6411
Open Access | Times Cited: 28
Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients
Irene Cassaniti, Marilena Gregorini, Federica Bergami, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 921-921
Open Access | Times Cited: 27
Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
Arnaud Devresse, Julien De Greef, Jean Cyr Yombi, et al.
Transplantation Direct (2022) Vol. 8, Iss. 3, pp. e1292-e1292
Open Access | Times Cited: 26
Characteristics of COVID-19 Breakthrough Infections among Vaccinated Individuals and Associated Risk Factors: A Systematic Review
Shilpa Gopinath, Angela Ishak, Naveen Dhawan, et al.
Tropical Medicine and Infectious Disease (2022) Vol. 7, Iss. 5, pp. 81-81
Open Access | Times Cited: 25
Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis
Mohammad-Mehdi Mehrabi Nejad, Parnian Shobeiri, Hojat Dehghanbanadaki, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 24
Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
Bilgin Osmanodja, Simon Ronicke, Klemens Budde, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 22
Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study
Dima Kabbani, Demitra M Yotis, Victor H. Ferreira, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 12
Comparison of antibody response to SARS-CoV-2 after two doses of inactivated virus and BNT162b2 mRNA vaccines in kidney transplant
Mariana Seija, Florencia Rammauro, José Luis Santiago, et al.
Clinical Kidney Journal (2021) Vol. 15, Iss. 3, pp. 527-533
Open Access | Times Cited: 28
Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination
Teresa Po‐Yu Chiang, Jennifer L. Alejo, Jonathan Mitchell, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 9, pp. 2254-2260
Open Access | Times Cited: 19
Assessment of humoral and cellular immune responses to SARS CoV‐2 vaccination (BNT162b2) in immunocompromised renal allograft recipients
Ruan Zhang, Bong‐Ha Shin, Terry‐Ann M. Gadsden, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 2
Open Access | Times Cited: 18
Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acid
Louise Benning, Christian Morath, Tessa Kühn, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 18
Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients
Louise Benning, Katrin Klein, Christian Morath, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top